Results 141 to 150 of about 1,417,901 (252)

Cost-Utility Analysis of Liraglutide in Type 2 Diabetes Patients in China after Chinese Reformation of Medical Care System

, 2018
Gao-Yu Xie, Suning Zhao
openalex   +2 more sources

A UK‐based cost–utility analysis of radiofrequency ablation or oesophagectomy for the management of high‐grade dysplasia in Barrett’s oesophagus [PDF]

, 2010
Philip Boger, David Turner, PJ Roderick, Preya Patel   +3 more
openalex   +1 more source

Cost-Utility Analysis of Anterior Vertebral Body Tethering versus Spinal Fusion in Idiopathic Scoliosis from a US Integrated Healthcare Delivery System Perspective

, 2021
David W. Polly, A. Noelle Larson, Amer F. Samdani, William D. Rawlinson, Hannah Brechka, A Porteous, W. Marsh, R. Ditto   +7 more
openalex   +2 more sources

Post-hospital medical respite care for homeless people in Denmark: a randomized controlled trial and cost-utility analysis [PDF]

, 2020
Camilla Nygaard Bring, Marie Kruse, Mikkel Zöllner Ankarfeldt, Nina Brünés, Maja Pedersen, Janne Petersen, Ove Andersen   +6 more
openalex   +1 more source

Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspective. [PDF]

Front Pharmacol
Hu D, Deng X, Feng M, Zhang X, He Q, Wang T, Feng Z.   +6 more
europepmc   +1 more source

PCH1: PAMIDRONATE FOR BREAST CANCER PATIENTS WITH SKELETAL METASTASES: A MARKOV TREE-BASED COST-UTILITY ANALYSIS

, 2000
NL Liberato, Marco Marchetti, A Tamburlini, Giovanni Barosi   +3 more
openalex   +1 more source

Cost-utility analysis of the Circle of Security-Parenting programme to reduce perinatal psychopathology in birthing parents in England. [PDF]

BMJ Open
Wang J, Rosan C, Alyousefi-van Dijk K, Darwin Z, Babalis D, Cornelius V, Waddingham E, Richards L, Pilling S, Fearon P, Fonagy P, Pizzo E.   +11 more
europepmc   +1 more source

Lifetime Cost-Utility Analysis of Emicizumab Prophylaxis in Severe Haemophilia A Without Inhibitors in China: A Markov Model Analysis. [PDF]

Haemophilia
Bao H, Bührer C, Lin Z, Zhou L, Xia Y, Jin X, Xuan J.   +6 more
europepmc   +1 more source

Cost-utility analysis of home mechanical ventilation compared to hospital settings in patients with chronic obstructive pulmonary disease. [PDF]

Cost Eff Resour Alloc
Gajdoš O, Rožánek M, Donin G, Kamenský V.   +3 more
europepmc   +1 more source

Cost-utility analysis of second line acromegaly treatment in France

Gérald Raverot, Philippe Chanson, Brigitte Delemer, D. Drui, Claire Briet, Amandine Ferrière, Maud Beillat, Wassila Aïssani, E. Cabout, Haifa Ben Romdhane, Thierry Brue   +10 more
openalex   +1 more source